Australia's largest stock trading and investment forum Australia's #1 stock forum

TB8

0.00%

13.0¢ tianmei beverage group corporation limited

Price predictions, page-349

First 349 Last

Share
Profile

Follow
beefarmer

15,308 Posts.

1410

19/08/17

07:39

Post #: 26604768
Share

Originally posted by beefarmer ↑

I hope this does not get moderated.............

Dear XXXXXXX,

How much *ing time do you *ing need to respond my my lovely *ing email?
For *s sake, you are supposed to be a professional *ing organization.
It is imperative you reply to requests like myself. You can’t be so god damn *ing busy that you haven’t got the common
*ing decency to acknowledge my simple request. What the * do you call yourself, a god damn hermit.
Very *ing disappointing XXXXXX. Don’t give me the bullshit that you are not around either. Business is 24hours a day
so get in the real *ing world and earn the money some chimp is paying you. You are supposed to be a *ing client adviser aren’t you
not some I don’t give a * type of person.

If you think I am greatly pissed off, you are *ing mistaken. I am not even *ing angry to be honest.
All I am is *ing pissed off with bad *ing manners. Where's the god damn *ing respect gone these days?

Now XXXXXX, see what you can come up with from the folk who are supposed to be running this show. As I said, you guys
flogged this off to the rest of us, get the company to help out with some information.

Not that *ing hard if you ask me. But who the * asked me in the first place. I wish they did.

Simple request really.

Expand

You will never believe the reply as sadly I didn't receive one. Pathetic.

TB8 Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

AI stocks: What to expect in 2024-25

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability